Skip to content

Morris Moscovitch

Baycrest Corporate Centre for Geriatric Care/Baycrest Academy for Research and Education, Scientist (Senior)

2024 Salary — last year on the list

$108,162

Total compensation $108,162, including $0 in taxable benefits.

Source: Ontario’s Public Sector Salary Disclosure — names paid $100,000 or more that year. How we build this · Report an error on this page

At a Glance
2024

Employer Rank

#82

Baycrest Corporate Centre for Geriatric Care

Years on List

1

2024–2024

Peak Salary

$108,162

2024

Full 2024 roster at Baycrest Corporate Centre for Geriatric Care →·See where $108,162 ranks →

Full History
2024–2024

Full salary history, by year
YearPositionSalary
2024Baycrest Academy for Research and Education, Scientist (Senior)Baycrest Corporate Centre For Geriatric Care$108,162Benefits $0Total $108,162

Take-Home Pay
(After Tax) · 2024 estimate

Morris Moscovitch was paid $108,162 in 2024; after income tax, CPP and EI that is roughly $79,350, an effective income-tax rate of about 21.9%. Within Baycrest Corporate Centre for Geriatric Care, Morris Moscovitch's total compensation of $108,162 was the #82 of 97, against a median salary of $141,967. 2024 is the first year Morris Moscovitch appears on the list. Members of OMERS, OTPP, HOOPP or OPTrust typically take home another 7–10% less after pension contributions, which this estimate leaves out.

Estimated net pay
~$79,350
Effective income-tax rate (excl. CPP/EI)
~21.9%
CPP + EI contributions
~$5,105
All-in deduction rate (incl. CPP/EI)
~26.6%

Where does $108,162 rank on the Sunshine List? →

Estimate only: 2024 federal and Ontario rates, basic personal amounts, Canada employment amount and CPP/EI credits; single, employment income only, salary treated as full-year income. Ignores pension contributions (OMERS, HOOPP, OTPP, OPTrust and similar plans lower actual take-home), union dues, RRSPs and benefits.

Also at Baycrest Corporate Centre for Geriatric Care
2024

View all 97 employees at Baycrest Corporate Centre for Geriatric Care (2024) →